Active Biotech AB Presents Data On Paquinimod At EULAR 2014
Published: Jun 11, 2014
LUND, Sweden, June 11, 2014 (GLOBE NEWSWIRE) -- Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data related to the drug candidate paquinimod (57-57) for the treatment of systemic sclerosis, at the scientific conference "EULAR Annual European Congress of Rheumatology" held in Paris on June 11-14, 2014.
Help employers find you! Check out all the jobs and post your resume.